[go: up one dir, main page]

AU2003270518A1 - Therapeutic anti-bgp(c-cam1) antibodies and uses thereof - Google Patents

Therapeutic anti-bgp(c-cam1) antibodies and uses thereof

Info

Publication number
AU2003270518A1
AU2003270518A1 AU2003270518A AU2003270518A AU2003270518A1 AU 2003270518 A1 AU2003270518 A1 AU 2003270518A1 AU 2003270518 A AU2003270518 A AU 2003270518A AU 2003270518 A AU2003270518 A AU 2003270518A AU 2003270518 A1 AU2003270518 A1 AU 2003270518A1
Authority
AU
Australia
Prior art keywords
cam1
bgp
antibodies
therapeutic anti
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003270518A
Other versions
AU2003270518A8 (en
Inventor
Atul Bhan
Richard S. Blumberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Brigham and Womens Hospital Inc
General Hospital Corp
Original Assignee
Brigham and Womens Hospital Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP20020020334 external-priority patent/EP1400535A1/en
Priority claimed from US10/241,369 external-priority patent/US20040047858A1/en
Application filed by Brigham and Womens Hospital Inc filed Critical Brigham and Womens Hospital Inc
Publication of AU2003270518A1 publication Critical patent/AU2003270518A1/en
Publication of AU2003270518A8 publication Critical patent/AU2003270518A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003270518A 2002-09-11 2003-09-11 Therapeutic anti-bgp(c-cam1) antibodies and uses thereof Abandoned AU2003270518A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP02020334.5 2002-09-11
EP20020020334 EP1400535A1 (en) 2002-09-11 2002-09-11 Therapeutic anti-BGP (C-CAM1) antibodies and uses thereof
US10/241,369 US20040047858A1 (en) 2002-09-11 2002-09-11 Therapeutic anti-BGP(C-CAM1) antibodies and uses thereof
US10/241,369 2002-09-11
PCT/US2003/028416 WO2004024746A2 (en) 2002-09-11 2003-09-11 Therapeutic anti-bgp(c-cam1) antibodies and uses thereof

Publications (2)

Publication Number Publication Date
AU2003270518A1 true AU2003270518A1 (en) 2004-04-30
AU2003270518A8 AU2003270518A8 (en) 2004-04-30

Family

ID=31995518

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003270518A Abandoned AU2003270518A1 (en) 2002-09-11 2003-09-11 Therapeutic anti-bgp(c-cam1) antibodies and uses thereof

Country Status (2)

Country Link
AU (1) AU2003270518A1 (en)
WO (1) WO2004024746A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9556271B2 (en) 2011-12-01 2017-01-31 The Brigham And Women's Hospital, Inc. Anti-CEACAM1 recombinant antibodies for cancer therapy

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4348376A (en) * 1980-03-03 1982-09-07 Goldenberg Milton David Tumor localization and therapy with labeled anti-CEA antibody

Also Published As

Publication number Publication date
WO2004024746A9 (en) 2004-06-10
WO2004024746A2 (en) 2004-03-25
WO2004024746A3 (en) 2004-07-29
AU2003270518A8 (en) 2004-04-30

Similar Documents

Publication Publication Date Title
EP1551447A4 (en) Anti-addl antibodies and uses thereof
WO2004040000A9 (en) G protein coupled receptors and uses thereof
AU2003253621A1 (en) Modified "s" antibodies
AU2003289742A1 (en) Stable therapeutic proteins
AU2003296369A1 (en) Imminoamines and preparation thereof
AU2003226899A1 (en) Human diabetes-mediating proteins
IL166063A0 (en) Antibodies and uses thereof
AU2003272423A1 (en) Centrosome proteins and uses thereof
AU2003207628A1 (en) Structural and cytoskeleton-associated proteins
AU2003231827A1 (en) Pseudo-tissues and uses thereof
AU2003302173A1 (en) Spirotetrathiocarbamates and spirooxothiocarbamates
AU2002953223A0 (en) Novel therapeutic molecules and uses thereof
AU2003240052A1 (en) Il-11 derivatives and therapeutic uses thereof
AU2003280992A1 (en) Novel proteins and use thereof
AU2003270518A1 (en) Therapeutic anti-bgp(c-cam1) antibodies and uses thereof
AU2003292774A1 (en) Novel proteins and use thereof
AU2003228397A1 (en) HAUSP-p53 INTERACTION AND USES THEREOF
AU2003216442A1 (en) Enkurin and uses thereof
AUPS243002A0 (en) Therapeutic target and uses thereof
AU2003263751A1 (en) Novel proteins and their uses
AU2003229752A1 (en) Human rhomboid-related protein
AU2002953561A0 (en) Peptides and therapeutic uses thereof
AU2003281314A1 (en) Nove protein and use thereof
AU2003249644A1 (en) MUTANT P53 (Delta126-132) PROTEIN AND USES THEREOF
AU2003265814A1 (en) Aw755252-interacting proteins and use thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase